Health is Wealth: MyFitnessPal's Third Annual Nutrition IQ Survey Exposes Americans' Nutritional Blind Spots Amid Rising Food Prices
As rising food costs continue to impact household decisions, MyFitnessPal's latest survey reinforces the importance of food tracking to stay on top of both nutrition and budget
NEW YORK, March 13, 2025 /PRNewswire/ -- MyFitnessPal, the leading global nutrition and food tracking app, has released their Nutrition IQ 3.0 survey1, following results from 2024 and 2022. The takeaway? A large majority of Americans still struggle with basic nutritional knowledge. Consistent with the past two surveys, 89% of people report that they don't have a clear understanding of how much protein, fiber, carbs, sugar, and salt they consume daily. Although 69% of survey respondents want to increase their protein intake, many do not recognize which foods offer the most nutritional value within their budget. Still, 87% of respondents agree that logging food helps them stay informed, making tools like MyFitnessPal invaluable in helping people make better, more informed food choices.
While the new year traditionally inspires health-oriented resolutions, current economic pressures are adding a layer of complexity. Rising food prices further complicate efforts to prioritize nutrient-dense options in grocery carts, creating a substantial barrier for many. Tracking food offers a practical solution, empowering consumers to make informed decisions that benefit both their health and their wallet.
'As food prices rise, it's more important than ever to make every dollar count by choosing foods that are both affordable and nutrient-dense,' said Melissa Jaeger, RD, LD, Head of Nutrition of MyFitnessPal. 'Tracking what you eat not only helps you understand your nutrient intake but can also help you identify nutrient-dense options that fit your budget. For example, if certain protein sources are currently out of reach due to price, options like beans, lentils, or canned tuna can provide protein at your meal at a lower cost. Education is key, and making informed decisions about your food is essential to maximizing both your health and your wallet.'
Along with a general gap in nutrition knowledge, increased food prices have changed the way Americans are buying food. A 2022 study from the University of Warwick found that Americans pay 40% more on fruits and vegetables due to high fixed costs, while a 2024 Research!America national poll reported that nearly two-thirds (60%) of Americans find the cost of healthy food a barrier to affording nutritious options. With rising food prices, it's important to make informed decisions about the foods that will provide the most nourishment for the cost. This year's MyFitnessPal survey reveals that cooking on a budget remains a top priority for Americans, but a striking 76% of survey participants also reported that they do not check nutritional values before dining out – highlighting that while people try to eat more mindfully at home, dining decisions continue to be driven by convenience and cost rather than nutritional quality.
Knowledge is power, and now consumers can test their nutrition prowess with MyFitnessPal's new Nutrition IQ Quiz for a realistic measure of where they can fill their own education gaps.
As one of the most trusted resources on nutrition, MyFitnessPal has refined the MyFitnessPal Scientific Advisory Council – a group of top experts from across the industry with diverse backgrounds and varied areas of expertise helping to shape the improved capabilities of the app. Returning members include Erin Palinski-Wade, RD, CDCES, who specializes in helping her clients manage their blood sugar and Type 2 diabetes, and Maya Feller, MS, RD, CDN, whose team focuses on medical nutrition therapy for metabolic conditions, mood disorders, and disordered eating. Joining the council for 2025 is Doctor Mike Varshavski, a board-certified family medicine physician and media personality who advocates for small lifestyle changes that have a big, lasting impact on health over time.
For more information on MyFitnessPal, visit www.myfitnesspal.com or download via App Store and Google Play.
About MyFitnessPal
MyFitnessPal is the #1 global nutrition and food tracking app founded in 2005 with a mission to help people around the world reach their health goals through better food choices by providing knowledge, motivation, and a sense of progress. Supporting nearly 1 million people in reaching their nutrition and fitness goals every year, and with a community of over 270 million users in 120 countries, MyFitnessPal offers members one of the world's most comprehensive nutrition and food tracking platforms, allowing them to track their food, record exercise activity, and log their weight. With one of the largest food databases in the world comprising over 20.5 million foods, access to over 2,000 recipes, more than 40 workout routines, and over 40 connected fitness partners, MyFitnessPal provides members with the tools for positive healthy change.
1 Research was fielded by MyFitnessPal in January 2025. MyFitnessPal surveyed 1,000 nationally representative participants between the ages of 18-64 across the United States.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
The cheap fat jabs sending big pharma into a frenzy
For many Americans who tuned in to watch the Super Bowl earlier this year, it was a surprise to find themselves fat-shamed during the ad break. 'Obesity is America's deadliest epidemic,' a voiceover said, as images of wobbling bellies, greasy burgers and giant apple pies flashed across TV screens. The Super Bowl's 127m-strong audience, who were tucking into an estimated 1.5bn chicken wings during the event, were warned that 'obesity leads to half a million deaths each year'. But Hims and Hers, the US online medicines company behind the ad, said people should not blame themselves. Instead, its advert claimed that 'the system' was keeping them 'sick and stuck', adding that 'there are medications that work, but they're priced for profits, not patients'. To the relief of viewers, Hims and Hers offered a 'life-changing' solution. Rather than paying hundreds of dollars each month for well-known, branded weight-loss jabs such as Wegovy, households could instead try Hims and Hers' cheaper, replica versions. 'This is the future of healthcare,' it argued. 'Join us in the fight for a healthier America.' However, for the likes of Danish obesity drug maker Novo Nordisk and US pharma rival Eli Lilly, which have claimed the rise of copycat jabs poses potential health risks, such claims have become a serious headache. Over the past few decades, both businesses have poured billions of dollars into obesity drug research – recently yielding blockbuster drugs Wegovy and Mounjaro. The rapid uptake of such drugs has prompted a surge in revenues for big pharma. But bosses are now increasingly worried that demand among American patients has been dented by a cluster of smaller, copycat companies. According to industry estimates from November, around a quarter of the 8m Americans on weight-loss drugs were taking knock-off replica versions. These medicines, known as 'compound' drugs, were priced at around $200 ($148) a month, compared to over $1,300 for some branded versions. Barclays analyst Emily Field says the boom in copycat weight-loss drugs has been a 'unique phenomenon' in the US, sparking an inevitable surge in legal claims that has drawn the attention of regulators. So-called compound drugs are essentially custom-made medicines created by pharmacies using the same active ingredients of patented drugs. Historically, compounding pharmacies create custom versions of medicines if they need to personalise them for patients. For example, if someone is unable to take a standard oral medicine in pill form, or is allergic to an ingredient in an existing medicine. Compounding pharmacies are also typically blocked from mass-producing their drugs. For weight-loss drugs, though, it has been a different story. After the US Food and Drug Administration (FDA) put semaglutide – marketed as the blockbuster obesity drug Wegovy – and tirzepatide – the same for Eli Lilly's Mounjaro – on the shortage list in 2022, compounders were allowed to ramp up production. 'It was almost like these companies found a loophole where they were allowed to do this on a mass scale,' says Field. The impact has been significant. At the start of this year, Novo Nordisk estimated that the copycat drugs accounted for around a third of the entire weight-loss market. That is despite warnings from the FDA about the health risks posed by compounded medicines, which do not have to be approved by the regulator. Beth, from Washington, says she was tempted by online ads for the compound medicines, having struggled with her weight since the pandemic. For her, the drugs helped her at a time when it seemed impossible to lose weight or stick to a diet. She dropped 30lbs over a few months of taking a compound weight-loss medicine. Others say they had little choice but to opt for compound versions, given that the branded medicines were too expensive and not covered by their health insurance. However, the situation is rapidly changing. Last month, the FDA banned mass production of copycat weight-loss treatments that use semaglutide, the ingredient in Novo Nordisk's Wegovy. It also removed tirzepatide from its shortage list last October. Novo Nordisk said the law has now made things clearer. 'Moving forward, any compounder that mass produces or sells knock-off drugs is breaking the law and compromising patient safety,' a spokesman said. Eli Lilly says the products 'pose potentially life-threatening health risks', adding: 'Patients shouldn't be exposed to risky, unapproved products when regulator-approved medicines are available.' Online medicines firms, also known as telehealth businesses, are now racing to find a way to continue getting cheaper, personalised replica drugs out to patients. Noom, a rival to Hims and Hers, has suggested it will still be able to sell compounded weight-loss drugs to patients under an exception set aside for 'personalised' medicines. Hims and Hers, meanwhile, has already struck a new deal with Novo to offer its branded obesity drug to patients. The US firm also said this month it was exploring expansion in the UK, after acquiring European rival Zava. Andrew Dudum, the Hims and Hers chief, suggested there could be 'expansive options in obesity that include that type of personalisation, or similar types', telling the Financial Times that it could sell replica obesity medicines in the UK and Europe. David Meinertz, the boss of Zava, agrees that there are opportunities for the business to grow outside of America. 'There's clearly the experience and expertise that Hims and Hers have built up in the US,' he says. 'But then we have things like the regulatory knowledge here in Zava, and this is where we combine our experiences and spearhead this effort.' Still, the situation in the UK is very different to the US. Here, the compounding pharmacy market is much smaller, with pharmacies able to prepare personalised medicines for patients if it is prescribed by a doctor. Elizabeth Philp, the co-founder of compounding pharmacy Roseway Labs, says there could be a role for more personalisation of medicines. 'The NHS will say wasted medication is one of their top issues – people who try medication, put it in their bathroom cupboard and never use it again because it didn't suit them,' she says. 'We can really help with that.' However, drug insiders argue it would be a 'very bad idea' if the UK started to think about bringing in cheaper compound medicines for weight loss. 'The real drugs are getting very cheap at volumes,' says one senior drug leader. 'Supply is not an issue.' It will be a message that Novo and Eli Lilly will seek to drum home as they seek to prevent smaller rivals from selling cheaper weight-loss medicines to patients. Still, the effects of this debate are already being felt by many in the US battling to lose weight. 'I cannot afford the full price at this time,' says Beth. 'I think it's awful that people are losing access to this medication due to finances or compounded meds going away. 'These drugs are literally life-changing.'
Yahoo
an hour ago
- Yahoo
9th Asia Agri-Tech Expo & Forum Opens Today, Driving Innovation in Asia-Pacific Agriculture
TAIPEI, June 11, 2025 /PRNewswire/ -- Organised by Informa Markets Asia Ltd., the 2025 Asia Agri-Tech Expo & Forum officially opened today (June 11) at the ICC Tainan. The grand opening ceremony gathered key representatives from government, industry, academia, and research to witness a new milestone in the advancement of agri-tech in the Asia-Pacific region. Distinguished guests attending the ribbon-cutting ceremony included Mr. Michael Duck, Executive Vice President of Informa Markets Asia, Deputy Mayor Yeh Tse-Shan of Tainan City Government, President Su Chih-Fen of the National Animal Industry Foundation, along with numerous prominent figures from various sectors. This year's event features over 150 exhibitors from around the world, showcasing cutting-edge innovations in agriculture automation, smart livestock farming, precision irrigation, crop monitoring, and feed technology. In addition to the exhibition, the event presents 10 key themes across 60 professional seminars, offering in-depth discussions on emerging trends in agriculture, smart livestock farming, advanced feed technology, and biosecurity upgrades. The three-day exhibition is expected to attract over 25,000 visitors. With Tainan serving as a central hub for agriculture and aquaculture in southern Taiwan, the event provides an ideal platform for farmers, growers, and industry professionals to explore the latest advancements. Many exhibitors are launching new products on-site, including: TOTAL NUTRITION: Combining peptide protein, probiotics, and acidifiers to form the "Golden Triangle" of gut health, achieving precise nutritional regulation and enhanced well-being. WONDER VAX: Introducing the Universal Live Vaccine for Infectious Bronchitis in Chickens (TW-I, TW-II), providing dual protection against respiratory and nephritis strains, precisely targeting Taiwan's prevalent local strains (TW-I, TW-II). YA SUH DAR: Launching a 50-inch butterfly shutter exhaust fan specifically designed for livestock farming. This large negative-pressure fan features an innovative pneumatic butterfly shutter design that effectively replaces traditional louver windows, significantly improving ventilation efficiency. It also offers excellent dustproof, corrosion-resistant, and weather-resistant performance, making it ideal for harsh environments with high temperatures and humidity. VETNOSTRUM: Comprehensive range of veterinary medicines, health products, feed additives, and feeds for pigs, cattle, sheep, poultry, and aquatic animals. AGRISTAR: Asia's first fully electric tractor, manufactured by Foxconn in the U.S., featuring Tesla technology and NVIDIA AI computing. Compatible with a variety of agricultural implements, it serves not only in dairy farming but also in a wide range of daily agricultural and livestock operations. This next-generation farming equipment paves the way for a net-zero carbon, sustainable agricultural future. Ms. Grace Lee, General Manager of Informa Markets Taiwan, stated: "Taiwan's agricultural sector boasts strong technological capabilities. Through this international platform, we foster knowledge exchange and drive innovation, enhancing global food self-sufficiency where Taiwan will play an increasingly pivotal role." The expo runs from June 11 to 13, open to industry professionals and related personnel free of charge. The organizers aim to foster cross-border collaboration and create a prosperous future for Asia-Pacific agriculture, paving the way for the next century of agricultural innovation. View original content to download multimedia: SOURCE Informa Markets Asia Ltd., Taiwan Branch Sign in to access your portfolio
Yahoo
3 hours ago
- Yahoo
Harrisburg restaurants react to Food Allergy Safety Legislation
HARRISBURG, Pa. (WHTM) — Right now there is no legislation in Pennsylvania that requires menus to have food allergy disclaimers. A bill to change that already passed the House. Restaurants abc27 spoke with agree the changes it would make are needed. House Bill 77 would also require restaurants to display a poster for their employees and have food allergy safety training. Millworks menu items that contain nuts or gluten are labeled. Front of House Manager Freddy Arundel says more and more customers are coming in with food allergies, which already prompted the restaurant to take precautions. 'The staff is trained to alert the kitchen about the allergies,' Arundel says. 'It's also flagged in our system on every ticket, so everyone who sees what's going on anywhere in the process and it's prepared separately and taken to the guest separately as well. Sauce Boss owner Sheri Tolomeo says gluten would be the main concern at her restaurant and she wouldn't mind updating her menus to disclose that. 'We could educate the people on it and then people can feel more comfortable when they come in ordering things because they know exactly what they're getting,' Tolomeo says. 'We can mix and match and make something that accommodates someone with an allergy.' Close Thanks for signing up! Watch for us in your inbox. Subscribe Now More than 33 million Americans have food allergies. That includes over one million in Pennsylvania. Bill sponsors say restaurants and other food retail facilities are the source of nearly half of all food allergy deaths. In a press conference on Tuesday, Kathy Briden spoke about her son Matthew who had a peanut allergy and died at age 28 after an accidental exposure. 'With a practical law in place, individuals and families living with food allergy may be more willing to extend trust when dining out, allowing Pennsylvania restaurants reap the economic benefits,' says Sung Poblete, chief executive officer of FARE (Food Allergy Research & Education). 'Ultimately, it is on the patron to inform the staff, but when the staff doesn't know what's in the food and just how deadly some of these reactions can be, we think that's the whole premise of House Bill 77,' says Rep. Natalie Mihalek (R-Allegheny and Washington Counties). House Bill 77 passed with bipartisan support in the House. Sen. Judith Schwank said in the Tuesday press conference that she's working on getting the Agriculture and Rural Affairs committee she co-chairs to get it on their agenda. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
